118 related articles for article (PubMed ID: 6237929)
1. Heparin inhibition of antibody-dependent complement-mediated lysis.
Wesolowski J; Ault K; Houghton R; Parkman R
Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
[TBL] [Abstract][Full Text] [Related]
2. Apparent interleukin 2 (IL-2) inhibitory activity of human serum is due to rapid killing of IL-2-dependent mouse cells.
Pruett SB; Lackey A
Clin Exp Immunol; 1987 Sep; 69(3):624-31. PubMed ID: 3117461
[TBL] [Abstract][Full Text] [Related]
3. Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins.
Goldmacher VS; Anderson J; Blättler WA; Lambert JM; Senter PD
J Immunol; 1985 Dec; 135(6):3648-51. PubMed ID: 2933450
[TBL] [Abstract][Full Text] [Related]
4. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
[TBL] [Abstract][Full Text] [Related]
5. [Lysis of leukemia cells with a monoclonal antibody-cocktail (e.g. VIP-pool) and human complement].
Reiners B; Thränhardt H; Häfer R; Zintl F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):84-96. PubMed ID: 2439421
[TBL] [Abstract][Full Text] [Related]
6. In vitro treatment of human acute lymphocytic leukemia cells in bone marrow with a cocktail of monoclonal antibodies.
Nakamura H; Hirayama F; Tatsumi Y; Tani Y; Kubota Y; Kanakura Y; Oguma S; Ueda T; Shibata H; Masaoka T
Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():537-42. PubMed ID: 6596454
[TBL] [Abstract][Full Text] [Related]
7. Distribution and modulation of a human leukemia-associated antigen (CALLA).
Pesando JM; Tomaselli KJ; Lazarus H; Schlossman SF
J Immunol; 1983 Oct; 131(4):2038-45. PubMed ID: 6225802
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.
Seon BK; Negoro S; Barcos MP; Tebbi CK; Chervinsky D; Fukukawa T
J Immunol; 1984 Apr; 132(4):2089-95. PubMed ID: 6607954
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of synergistic complement-mediated lysis of rat red cells by monoclonal IgG antibodies.
Hughes-Jones NC; Gorick BD; Howard JC
Eur J Immunol; 1983 Aug; 13(8):635-41. PubMed ID: 6603980
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
11. Antibody lysis of human hematopoietic cells in the absence of complement and effector cells.
Lozzio CB; Lozzio BB; Wust CJ; Bamberger EG; Golde DW; Minowada J
Exp Hematol; 1982 Sep; 10(8):698-707. PubMed ID: 6183138
[TBL] [Abstract][Full Text] [Related]
12. Difference between monoclonal antibodies against the common acute leukemia antigen from two different hybridomas.
Canon C; Eichler-Reiss F; Reizenstein P; Mathé G
Anticancer Res; 1983; 3(6):407-8. PubMed ID: 6230985
[TBL] [Abstract][Full Text] [Related]
13. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes. II. Comparison with polymorphonuclear leukocytes against erythrocyte and nucleated target cells.
Fuson EW; Shaw MW; Hubbard RA; Sugantharaj DG; Lamon EW
Exp Hematol; 1981 Feb; 9(2):197-206. PubMed ID: 7238651
[TBL] [Abstract][Full Text] [Related]
15. Comparison of monocyte and complement mediated haemolysis of human A1 erythrocytes: the relationship between antibody, target and effector concentrations in the induction of lysis.
Bakács T; Tótpál K; Ringwald G; Yefenof E
J Clin Lab Immunol; 1988 Feb; 25(2):53-8. PubMed ID: 3373517
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement.
Imai M; Ohta R; Varela JC; Song H; Tomlinson S
Cancer Res; 2007 Oct; 67(19):9535-41. PubMed ID: 17909064
[TBL] [Abstract][Full Text] [Related]
17. Role of antigen density in immune lysis of interferon-treated human lymphoid cells: analysis with monoclonal antibodies to the HLA-A,B antigenic molecular complex and to Ia-like antigens.
Imai K; Pellegrino MA; Ng AK; Ferrone S
Scand J Immunol; 1981 Nov; 14(5):529-35. PubMed ID: 6175019
[TBL] [Abstract][Full Text] [Related]
18. [Cyto-destruction of leukemic blasts in vitro using a monoclonal antibody and complement].
Pérez-Oteyza J; Brieva JA; Odriozola J; Bootello A; Navarro JL
Sangre (Barc); 1986; 31(5):587-92. PubMed ID: 2949378
[No Abstract] [Full Text] [Related]
19. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
20. In vitro antitumoral activity of baculovirus-expressed chimeric recombinant anti-CD4 antibody 13B8.2 on T-cell lymphomas.
Troadec S; Chentouf M; Cérutti M; Nguyen B; Olive D; Bès C; Chardès T
J Immunother; 2007; 30(2):190-202. PubMed ID: 17471166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
